Horner Syndrome

Horner syndrome is a clinical triad resulting from disruption of the oculosympathetic pathway at any point along its three-neuron arc, from the hypothalamus through the brainstem, cervical spinal cord, neck, and orbit. The classic triad consists of miosis (constricted pupil), ptosis (drooping eyelid), and anhidrosis (decreased sweating), though the presentation varies based on the anatomical location of the lesion. With an incidence of approximately 1 per 6,250 hospital admissions and a prevalence of 0.5–2 per 1,000 population, Horner syndrome represents an important neurological sign that localizes pathology to the sympathetic nervous system. Clinical recognition is essential because identifying the underlying cause—ranging from benign to life-threatening conditions such as carotid artery dissection, lung malignancy, or spinal cord pathology—fundamentally guides diagnostic workup and management. For USMLE Step 2 CK, Horner syndrome serves as a critical consolidation point for understanding neuroanatomical pathways, sympathetic physiology, and systematic diagnostic reasoning in neuro-ophthalmology.

The oculosympathetic pathway consists of three sequential neurons whose interruption at any level produces Horner syndrome through loss of sympathetic tone to ocular and periocular structures:

The oculosympathetic pathway originates in the hypothalamus (dorsomedial and posterior nuclei), descends ipsilaterally through the brainstem (particularly the medial medulla), continues through the cervical spinal cord (C8-T2 levels, terminating in the ciliospinal center of Budge), and synapses in the intermediolateral cell column (IML). Lesions along this central pathway—including brainstem stroke, syrinx, demyelination, or spinal cord injury—interrupt preganglionic sympathetic outflow. The loss of norepinephrine-mediated stimulation of Müller's muscle (superior tarsal muscle) reduces its contractility, causing ptosis (typically 1-2 mm, less profound than third-nerve palsy). Simultaneously, loss of sympathetic tone to the dilator pupillae muscle prevents pupillary dilation, resulting in miosis (pupil constriction to 1-2 mm smaller than contralateral side). Central lesions affecting hypothalamic projections to the T1-T2 spinal segments also cause ipsilateral anhidrosis (loss of sweating on the face, neck, arm, and trunk), as preganglionic fibers mediating sudomotor function are interrupted before synapsing in the superior cervical ganglion.

After exiting the spinal cord at T1, preganglionic sympathetic fibers form the T1 sympathetic root and course through the stellate ganglion (formed by fusion of the inferior cervical and first thoracic ganglia), then ascend alongside the carotid artery through the neck within the carotid sheath. Preganglionic lesions include Pancoast tumor (superior sulcus lung malignancy), brachial plexus injuries, cervical lymphadenopathy, carotid artery dissection, thyroid pathology, aortic arch disease, and surgical complications (carotid endarterectomy, coronary artery bypass). The physiological result mirrors central lesions: interruption of norepinephrine release at the superior cervical ganglion prevents activation of postganglionic neurons, thus blocking the two-stage sympathomimetic cascade necessary for pupillary dilation and eyelid elevation. Preganglionic Horner syndrome characteristically includes hemifacial anhidrosis (reduced sweating on the ipsilateral forehead and face), though sweating may be preserved in the neck and upper extremity if the lesion is distal to T1. A distinctive feature is the presence of dilation lag: when darkness-adapted, the affected pupil dilates more slowly than the normal pupil, with maximal asymmetry appearing 15-20 seconds after darkening (normal pupil reaches maximum dilation in 15 seconds; Horner pupil may take 20 seconds or longer). This "pharmacological" dilation lag results from the reduced capacity of postganglionic sympathetic terminals to release norepinephrine rapidly.

Postganglionic fibers originate in the superior cervical ganglion (located at the level of C2-C3, at the carotid bifurcation), ascend along the internal carotid artery through the cavernous sinus, and travel with the ophthalmic division of the trigeminal nerve (CN V1) to innervate the dilator pupillae and Müller's muscle. Postganglionic lesions include cavernous sinus thrombosis, carotid dissection, Raeder paratrigeminal syndrome (inflammation around the trigeminal nerve at the base of the skull), and idiopathic (most common preganglionic and postganglionic causes, ~25-50% of all Horner cases). The cardinal physiological defect in postganglionic Horner is loss of the final sympathetic relay, preventing norepinephrine synthesis and release from postganglionic terminals in the orbit. Clinically, postganglionic Horner presents with the classic triad but lacks hemifacial anhidrosis (sweating is preserved because sudomotor preganglionic fibers have already synapsed in the superior cervical ganglion), making anhidrosis distribution a crucial localizing sign. Postganglionic lesions also produce a characteristic reversed dilation lag or slow redilatation: while the pupil still dilates slowly, it may show increased sensitivity to topical sympathomimetics (apraclonidine or cocaine), as postganglionic denervation upregulates receptor sensitivity in postganglionic neuron terminals.

The dilator pupillae and Müller's muscle are innervated exclusively by α1-adrenergic receptors, which mediate smooth muscle contraction via phospholipase C activation, IP3-dependent intracellular calcium release, and sustained muscle contraction. In normal physiology, sympathetic nerve terminals continuously synthesize and release norepinephrine (synthesized from tyrosine via DOPA decarboxylase), which activates postsynaptic α1 receptors to maintain pupil size and eyelid height. In Horner syndrome, loss of norepinephrine release—whether central, preganglionic, or postganglionic—eliminates tonic α1-adrenergic stimulation, reducing pupil diameter and eyelid tone. This explains why cocaine (which blocks presynaptic norepinephrine reuptake and increases synaptic norepinephrine concentration) fails to dilate the Horner pupil: in postganglionic denervation, no norepinephrine is available for cocaine to "rescue," whereas in preganglionic or central denervation, preganglionic terminals (still present) cannot release adequate norepinephrine even with reuptake blockade. Conversely, apraclonidine (α2-adrenergic agonist) and hydroxyamphetamine (indirect sympathomimetic that releases norepinephrine from intact nerve terminals) show different sensitivities based on lesion location. Hydroxyamphetamine effectively dilates postganglionic and central Horner pupils (because preganglionic terminals are intact) but fails in preganglionic lesions (no intact terminals available to release norepinephrine). This pharmacological dissociation forms the basis of the diagnostic pharmacological test cascade.

The dilation lag phenomenon results from reduced norepinephrine availability at postganglionic terminals in Horner syndrome. In darkness, the dilator pupillae normally contracts within 15 seconds to achieve maximum dilation (pupil diameter increase of 1-3 mm). In Horner syndrome, the affected pupil dilates more slowly because of blunted α1-adrenergic tone, with maximal dilation delayed 15-20 seconds or longer after the normal pupil. Quantitatively, at 15 seconds after onset of darkness, the anisocoria (pupil size difference) in Horner syndrome appears maximal or near-maximal, whereas normal individuals show minimal anisocoria at this timepoint. This dilation lag is proportionally more pronounced in acute Horner syndrome (hours to days after lesion onset) because the postganglionic sympathetic terminal has not yet undergone compensatory upregulation of adrenergic receptors. In chronic Horner syndrome (weeks to months), postganglionic denervation supersensitivity develops through increased α1-receptor density, partially restoring responsiveness to norepinephrine and diminishing the dilation lag. Additionally, in postganglionic denervation, redilatation lag (slower return to baseline pupil size after light stimulus) may develop, contributing to the overall pupil dynamics abnormality.

Horner syndrome etiologies are conventionally classified by anatomical level of lesion, with distinct epidemiological profiles and clinical implications:

Central lesions account for approximately 5-15% of symptomatic Horner cases and involve the hypothalamus, brainstem, or cervical spinal cord. Brainstem stroke (particularly medullary infarction involving the lateral medulla in Wallenberg syndrome) is a classic presentation combining Horner syndrome with contralateral spinothalamic loss, ipsilateral palatal weakness, and cerebellar signs; the medullary location disrupts the descending oculosympathetic pathway. Multiple sclerosis and other demyelinating diseases can affect the cervical spinal cord, interrupting the ciliospinal center fibers. Spinal cord trauma, syrinx, Chiari malformation, and tethered spinal cord represent additional central etiologies. Brainstem tumors (including glioma and metastases) and demyelinating lesions are less common but important considerations. Central Horner syndrome classically presents with hemifacial anhidrosis (including forehead), distinguishing it from postganglionic causes; however, anhidrosis may occasionally be absent if the lesion is rostral to the ciliospinal center (above T1).

Preganglionic Horner represents 25-50% of symptomatic cases and presents the broadest etiological spectrum. Pancoast tumor (squamous cell carcinoma of the lung's superior sulcus) classically causes preganglionic Horner through invasion or compression of the brachial plexus and stellate ganglion; it occurs in 25-50% of Pancoast tumors and mandates urgent chest imaging (CXR and CT) in any adult with new Horner syndrome. Neck malignancy (lymphoma, metastases, thyroid cancer) and lymphadenopathy (tuberculosis, sarcoidosis, malignancy) may compress preganglionic fibers. Carotid artery dissection (spontaneous or traumatic) causes preganglionic Horner through compression or ischemia of sympathetic fibers traveling alongside the carotid artery; dissection is an important acute cause in younger patients with sudden Horner onset and may present with neck pain, headache, or focal neurological deficits. Aortic arch aneurysm and aortic dissection can compress the left sympathetic chain. Thyroid pathology (surgery, cancer, Hashimoto's thyroiditis) and parathyroid disease may affect the sympathetic chain during surgical manipulation or inflammatory infiltration. Brachial plexus injury (from trauma, birth injury, or surgical complication) interrupts preganglionic fibers at their origin. Stellate ganglion blockade (iatrogenic, from regional anesthesia or pain management procedures) transiently impairs sympathetic transmission. Trauma to the neck and birth trauma (particularly in Erb's palsy) represent important preganglionic etiologies. Approximately 25-50% of preganglionic Horner cases are idiopathic, particularly in younger patients without imaging abnormalities; these likely represent minor vascular events or self-limited inflammation that resolves without clinical sequelae.

Postganglionic Horner accounts for 20-25% of cases and includes idiopathic postganglionic Horner (the most frequent specific diagnosis in many series, representing 15-25% of all Horner cases), cavernous sinus thrombosis (from sinusitis, orbital cellulitis, or thrombophilia), Raeder paratrigeminal syndrome (characterized by hemicranial headache, postganglionic Horner, and trigeminal involvement without other CN deficits; often idiopathic or associated with internal carotid artery dissection), and carotid dissection (when the dissection is sufficiently distal to spare preganglionic fibers but affects postganglionic fibers in the cavernous sinus). Orbital masses (cavernous hemangioma, lymphoma, primary tumors) and orbital inflammation may compress postganglionic fibers. Cluster headache has been associated with transient postganglionic Horner during acute headache episodes. Internal carotid artery dissection is a critical diagnosis not to miss, presenting with acute Horner syndrome, ipsilateral neck pain, headache, and potentially stroke from arterial occlusion or thromboembolism.

Congenital Horner syndrome is rare but clinically distinctive and important for pediatric and obstetric contexts. Causes include birth trauma (forceps injury to brachial plexus or stellate ganglion), neuroblastoma (particularly left-sided, affecting the sympathetic chain), brachial plexus injury, and developmental abnormalities of the sympathetic chain. The key distinguishing feature in congenital Horner is iris heterochromia: the affected eye's iris is lighter (hypopigmented) than the contralateral eye because sympathetic innervation is important for normal iris pigment deposition during development. This heterochromia is pathognomonic for congenital postganglionic Horner or congenital preganglionic Horner, developing over months to years and appearing irreversible. In contrast, acquired Horner syndrome does not produce heterochromia. Iris heterochromia in an adult with Horner syndrome indicates that the syndrome was present since childhood (likely undiagnosed until adulthood when other symptoms prompted evaluation).

Harlequin sign (hemifacial flushing and sweating asymmetry) may occur in infants with Horner syndrome as a manifestation of immature thermoregulation; transient infant Horner has been described in association with birth trauma and typically resolves. Smoking (particularly heavy smoking and tobacco chewing) has been associated with idiopathic preganglionic Horner in some epidemiological studies. Migraine and cluster headache may transiently present with Horner-like features during acute attacks due to sympathetic dysregulation, though permanent Horner syndrome is rare unless underlying vascular pathology coexists.

Horner syndrome manifests with a spectrum of signs and symptoms, determined by the anatomical level of lesion, acuity of onset, and degree of sympathetic denervation. The classic triad of miosis, ptosis, and anhidrosis is often incomplete, particularly in acute presentations:

Miosis is the hallmark of Horner syndrome and results from loss of α1-adrenergic stimulation to the dilator pupillae muscle, preventing active pupillary dilation. The affected pupil is typically 1-2 mm smaller than the contralateral eye, with the asymmetry more apparent in darkness (where pupillary dilation normally maximizes the difference in pupil size). In bright light, miosis may be subtle or imperceptible because both pupils constrict via parasympathetic activation (sphincter pupillae), masking the sympathetic deficit

Diagnosis proceeds in two steps — confirm that anisocoria is sympathetic, then localize the lesion — and there is no named scoring system for Horner syndrome.

Horner syndrome is a sign, not a disease — no professional society publishes a Horner-specific treatment guideline, and management is directed entirely at the underlying lesion.